Invention Application
US20140234299A1 THERAPIES FOR CHRONIC RENAL FAILURE USING ONE OR MORE INTEGRIN ANTAGONISTS
审中-公开
使用一个或多个INTEGRIN ANTAGONISTS治疗慢性肾衰竭的治疗方法
- Patent Title: THERAPIES FOR CHRONIC RENAL FAILURE USING ONE OR MORE INTEGRIN ANTAGONISTS
- Patent Title (中): 使用一个或多个INTEGRIN ANTAGONISTS治疗慢性肾衰竭的治疗方法
-
Application No.: US14158764Application Date: 2014-01-17
-
Publication No.: US20140234299A1Publication Date: 2014-08-21
- Inventor: Roy Lobb , Charles Pusey , Andrew Allen
- Applicant: Imperial College of Science, Technology and Medicine , Biogen Idec MA Inc.
- Applicant Address: GB London US MA Cambridge
- Assignee: Imperial College of Science, Technology and Medicine,Biogen Idec MA Inc.
- Current Assignee: Imperial College of Science, Technology and Medicine,Biogen Idec MA Inc.
- Current Assignee Address: GB London US MA Cambridge
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K31/702 ; A61K38/08
Abstract:
The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain integrin antagonists.
Information query
